Teva Pharmaceutical ADR
| Region | Europa |
| ISIN | US8816242098 |
| Sektor | Chemie & Pharma |
| Website | http://www.tevapharm.com/ |
Teva Pharmaceuticals gehört zu den weltweit wichtigsten Pharmaunternehmen und gilt als größter Generika Hersteller.
| Titel | Datum |
|---|---|
|
Medincell Partner Teva to Host Investor Call on Completed Phase 3 Olanzapine LAI Data Following Psych Congress 2025 Presentation
Regulatory News: Medincell (Paris:MEDCL): Data from the completed phase 3 SOLARIS trial to be pr... |
vor einem Tag |
|
Teva Pharmaceutical Industries Ltd: Teva to Host Conference Call to Discuss Data from the Completed Phase 3 SOLARIS Trial For Olanzapine ...
TEL AVIV, Israel, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE an... |
vor 2 Tagen |
| Teva Pharmaceutical Industries Limited (TEVA)'s Emrusolmin Gains FDA Fast Track for Multiple System Atrophy | vor 2 Tagen |
| Here's Why Sound Shore Fund Added Teva Pharmaceutical Industries Limited (TEVA) in Q2 | vor 8 Tagen |
| Teva gets FDA fast track status for multiple system atrophy drug | vor 9 Tagen |
| Diese Aktien könnten Dich auch interessieren | |
|---|---|
| Tesla (3 Artikel) | |
| Telit Communications (3 Artikel) | |
| The Naga Group (2 Artikel) | |
| The Priceline Group (2 Artikel) | |
| Alle anzeigen | |